Willis Towers Watson (WTW) Q4 2025 earnings summary

Executive summary

• Achieved strong Q4 and full-year organic revenue growth of 6% and 5%, respectively, with significant margin expansion, driven by strategic focus, talent investment, and portfolio optimization.

• Accelerated performance through specialization, innovation, and strategic acquisitions, including Newfront, Cushon, and FlowStone Partners, while divesting TRANZACT to optimize the business mix.

• Returned $2B to shareholders in 2025 via $1.65B share repurchases and $400M dividends, maintaining disciplined capital allocation.

• Digital platforms, data analytics, and AI-driven efficiency initiatives contributed to growth and margin expansion.

• Net income for the year was $1.61B, rebounding from a prior year loss due to impairment charges.

Financial highlights

• Q4 organic revenue growth of 6%, adjusted operating margin up 80 bps to 36.9%, adjusted EPS $8.12 (up 13% YoY excluding TRANZACT).

• Full-year organic growth of 5%, adjusted operating margin up 130 bps to 25.2%, adjusted EPS $17.08 (up 13% YoY excluding TRANZACT).

• Free cash flow for 2025 was $1.55B, up $279M YoY, with a margin of 15.9%.

• Q4 2025 revenue was $2.94B (down 3% YoY); full-year revenue was $9.71B (down 2%), primarily due to the TRANZACT sale.

• Q4 income from operations rose 13% to $1.02B; full-year income from operations surged 256% to $2.23B.

Outlook and guidance

• 2026 guidance: mid-single-digit organic growth, adjusted operating margin and free cash flow margin expansion, with share repurchases of $1B+ planned.

• HWC expected to deliver high single-digit growth; R&B mid- to high-single-digit growth; Career mid-single-digit growth; BD&O low single-digit growth (with recovery to mid-single-digit beyond 2026).

• Foreign exchange expected to be a $0.30 tailwind to adjusted EPS in 2026.

• Newfront acquisition expected to be ~$0.10 dilutive to adjusted EPS in 2026, with $250M post-close revenue and ~26% adjusted EBITDA margin.

• Expecting ~100 bps annual margin expansion in Risk & Broking and incremental expansion in Health, Wealth & Career over the next two years.